Literature DB >> 3021839

Horseradish peroxidase-catalyzed oxidation of mitoxantrone: spectrophotometric and electron paramagnetic resonance studies.

K Reszka, P Kolodziejczyk, J W Lown.   

Abstract

The clinical anticancer agent mitoxantrone is subject to irreversible oxidation by hydrogen peroxide catalyzed by horseradish peroxidase (HRP). The characteristic absorption changes that result provide evidence for an initial metabolite which is further oxidized enzymatically. The formation of the metabolite is accompanied by the concomitant generation of a free radical species detected by EPR spectroscopy. The intensity of the latter is dependent on the ratio of mitoxantrone to oxidant as well as on the pH of the medium. The metabolite in its oxidized form is a strong electrophile and can be reduced by biologically and physiologically relevant electron donors including ascorbic acid, L-cysteine and reduced glutathione. The results establish a new facile metabolic conversion of this clinically useful anticancer agent that may be relevant to its mode of action.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021839     DOI: 10.1016/0748-5514(86)90120-0

Source DB:  PubMed          Journal:  J Free Radic Biol Med        ISSN: 0748-5514


  6 in total

1.  Mimicry between mitochondrial disorder and multiple sclerosis.

Authors:  Josef Finsterer; Romana Höftberger; Claudia Stöllberger; Boris Rolinski
Journal:  Metab Brain Dis       Date:  2012-02-05       Impact factor: 3.584

2.  Localization and molecular interactions of mitoxantrone within living K562 cells as probed by confocal spectral imaging analysis.

Authors:  A Feofanov; S Sharonov; I Kudelina; F Fleury; I Nabiev
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

3.  Quantitative confocal spectral imaging analysis of mitoxantrone within living K562 cells: intracellular accumulation and distribution of monomers, aggregates, naphtoquinoxaline metabolite, and drug-target complexes.

Authors:  A Feofanov; S Sharonov; F Fleury; I Kudelina; I Nabiev
Journal:  Biophys J       Date:  1997-12       Impact factor: 4.033

4.  Lack of involvement of reactive oxygen in the cytotoxicity of mitoxantrone, CI941 and ametantrone in MCF-7 cells: comparison with doxorubicin.

Authors:  G R Fisher; L H Patterson
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 5.  Rationale for the use of aliphatic N-oxides of cytotoxic anthraquinones as prodrug DNA binding agents: a new class of bioreductive agent.

Authors:  L H Patterson
Journal:  Cancer Metastasis Rev       Date:  1993-06       Impact factor: 9.264

6.  The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived Hep G2 hepatoma cells.

Authors:  S J Duthie; M H Grant
Journal:  Br J Cancer       Date:  1989-10       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.